Skip to search formSkip to main contentSkip to account menu

Carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu]

Known as: Carbaglu 200 MG Dispersible Tablet for Oral Suspension, Carbaglu 200 MG Tablet for Oral Suspension, Carglumic acid 200 mg ORAL TABLET [Carbaglu] 
National Institutes of Health

Related topics

Related topics

8 relations
CarbagluCarglumic acidCroscarmellose SodiumSilicon Dioxide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Carglumic acid (Carbaglu®) treatment in hyperammonemia post liver transplantation.
2019
2019
Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial
IntroductionPropionic acidemia (PA) and methylmalonic acidemia (MMA) are rare autosomal recessive inborn errors of metabolism… 
2019
2019
Carglumic acid in hyperammonaemia due to organic acidurias: a profile of its use in the EU
Carglumic acid (N-carbamylglutamate; Carbaglu®), a structural analog of N-acetylglutamate, is an effective and generally well… 
2017
2017
Normal Neurological Development During Infancy Despite Massive Hyperammonemia in Early Treated NAGS Deficiency.
A girl born at term was admitted to the neonatal intensive care unit because of mild respiratory distress after a complicated… 
Review
2012
Review
2012
Carglumic acid for the treatment of N-acetylglutamate synthase deficiency and acute hyperammonemia
Carglumic acid is a structural analog and the first registered synthetic form of the naturally occurring allosteric activator of… 
2004
2004
9 Deviations from Regular Resting Energy Expenditure in Severely Disabled Children
Background: The resting energy expenditure (REE) in children is well investigated and has been clearly defined by the WHO in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)